Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
12:12pm, Wednesday, 03'rd Jun 2026
Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Charles River Associates (CRA) to Present at the Sidoti Small-Cap Virtual Conference
08:30am, Wednesday, 03'rd Jun 2026
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the Company will partici
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript
06:01pm, Tuesday, 02'nd Jun 2026
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Charles River Laboratories to Present at William Blair and Jefferies Conferences
08:00am, Monday, 01'st Jun 2026
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46th Annual Growth Stock Conference on Tue
Pre-Market Stock Futures: Futures are trading higher after yet another winning day for Wall Street, as all major indices finished the day higher after starting the session lower. Once again, all four
Charles River Laboratories International Inc (CRL) Shares Surge 5.0% -- What GF Score of 72 Tells Investors
07:40pm, Wednesday, 27'th May 2026
Valuation Assessment of Charles River Laboratories International Inc (CRL) On May 27, 2026, Charles River Laboratories International Inc (CRL) shares experience
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Wednesday, 20'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
09:00am, Wednesday, 13'th May 2026
Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to colla
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
08:00am, Wednesday, 13'th May 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU
Charles River Laboratories International Inc (CRL) Stock Down 5.2% -- Now Undervalued? GF Score: 79/100
01:23am, Tuesday, 12'th May 2026
On May 12, 2026, Charles River Laboratories International Inc (CRL) shares fell 5.2%, bringing the current price to $168.46. The stock has experienced a 52-week
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
10:16am, Monday, 11'th May 2026
Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
08:00am, Monday, 11'th May 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to
Charles River Laboratories International Q1 Earnings Call Highlights
07:05pm, Saturday, 09'th May 2026
Charles River Laboratories International NYSE: CRL reported first-quarter 2026 results that management said were in line to slightly ahead of its prior outlook, while reaffirming its full-year organic
LH vs. CRL: Which Stock Is the Better Value Option?
12:41pm, Friday, 08'th May 2026
Investors interested in stocks from the Medical Services sector have probably already heard of Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two stocks offers value in
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
11:11am, Friday, 08'th May 2026
Charles River Laboratories International, Inc. (NYSE:CRL) posted upbeat earnings for the first quarter, but lowered its FY2026 forecast on Thursday.
